STIFEL FINANCIAL CORP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$4,545,290
+3.7%
293,813
+5.3%
0.01%0.0%
Q2 2023$4,383,853
-3.3%
279,047
+1.4%
0.01%
-14.3%
Q1 2023$4,535,116
+156.7%
275,188
+143.0%
0.01%
+133.3%
Q4 2022$1,767,006
+10.2%
113,269
-8.4%
0.00%0.0%
Q3 2022$1,604,000
+5.3%
123,697
+14.0%
0.00%
+50.0%
Q2 2022$1,523,000
+10.9%
108,515
+13.2%
0.00%0.0%
Q1 2022$1,373,000
+15.9%
95,836
+10.2%
0.00%0.0%
Q4 2021$1,185,000
-5.7%
86,952
+13.3%
0.00%0.0%
Q3 2021$1,257,000
+15.7%
76,740
+18.9%
0.00%0.0%
Q2 2021$1,086,000
-7.3%
64,562
+0.6%
0.00%0.0%
Q1 2021$1,172,000
-59.1%
64,179
-59.2%
0.00%
-60.0%
Q4 2020$2,863,000
-20.0%
157,304
-21.5%
0.01%
-28.6%
Q3 2020$3,577,000
-2.5%
200,489
-2.0%
0.01%
-12.5%
Q2 2020$3,668,000
+10.5%
204,606
-6.4%
0.01%
-11.1%
Q1 2020$3,320,000
-22.0%
218,665
+1.3%
0.01%0.0%
Q4 2019$4,255,000
+30.1%
215,814
+13.5%
0.01%
+12.5%
Q3 2019$3,271,000
-11.2%
190,165
-8.6%
0.01%
-11.1%
Q2 2019$3,683,000
-10.1%
208,056
+3.2%
0.01%
-25.0%
Q1 2019$4,097,000201,5180.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders